Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for GNGBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 5.928B
March 31, 2026 6.090B
December 31, 2025 6.499B
September 30, 2025 6.038B
June 30, 2025 5.915B
March 31, 2025 6.000B
December 31, 2024 5.962B
September 30, 2024 5.881B
June 30, 2024 5.215B
March 31, 2024 5.267B
December 31, 2023 5.467B
September 30, 2023 4.928B
June 30, 2023 4.892B
March 31, 2023 4.917B
December 31, 2022 5.124B
September 30, 2022 4.677B
June 30, 2022 4.731B
March 31, 2022 4.877B
December 31, 2021 4.921B
September 30, 2021 4.962B
June 30, 2021 4.871B
March 31, 2021 5.143B
December 31, 2020 5.632B
September 30, 2020 5.388B
June 30, 2020 5.296B
Date Value
March 31, 2020 4.874B
December 31, 2019 4.776B
September 30, 2019 4.737B
June 30, 2019 4.858B
March 31, 2019 4.831B
December 31, 2018 4.890B
September 30, 2018 4.793B
June 30, 2018 4.858B
March 31, 2018 5.021B
December 31, 2017 5.142B
September 30, 2017 6.329B
June 30, 2017 6.264B
March 31, 2017 6.141B
December 31, 2016 6.334B
September 30, 2016 6.332B
June 30, 2016 6.321B
March 31, 2016 6.462B
December 31, 2015 6.314B
September 30, 2015 6.386B
June 30, 2015 6.439B
March 31, 2015 6.442B
December 31, 2014 6.776B
September 30, 2014 6.755B
June 30, 2014 7.022B
March 31, 2014 6.991B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Xvivo Perfusion AB 261.09M
Paxman AB 50.44M
Enovis Corp. 3.766B
Edwards Lifesciences Corp. 13.87B
Intuitive Surgical, Inc. 20.88B

Total Assets (Quarterly) Related Metrics